Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
D000818:Animals; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide / Q000494:pharmacology*; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D007093:Imidazoles / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced*; D012110:Reserpine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D013997:Time Factors
D007093:Imidazoles; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; D007980:Levodopa; D012110:Reserpine; D004299:Dopamine beta-Hydroxylase